Featured Articles
-
How AI Is Reshaping Trial Design, Execution, And Disclosure
9/25/2025
AI has quietly embedded itself into the operational heart of clinical development, where it is accelerating decisions, reducing manual burden, and improving outcomes.
-
A New Blueprint For Transforming Feasibility And Recruitment
9/22/2025
Discover how a connected approach links feasibility and recruitment, using real-world data to design realistic protocols, reach the right patients, and accelerate enrollment with confidence.
-
Real-World Data Has Real Impact On Clinical Research
9/18/2025
The ultimate goal of using real-world data (RWD) in clinical research is to ensure a patient is on the right therapy and receiving the right care at the right point in their healthcare journey.
-
AI Won't Replace You — But Clinical Teams Using It Might
9/18/2025
Join experts as they reveal how AI is being used today across feasibility, site selection, and trial strategy — and why success depends on pairing AI with high-quality, expert-backed data.
-
Infographic: Every Completed Trial, Every Emerging Trend
9/18/2025
Explore the data behind every trial completed last year — uncovering key trends, leading sponsors, and therapeutic areas shaping the future of clinical research.
-
Biotech Landscape Continues To Shift
9/18/2025
Global shifts are adding new layers of challenge and opportunity for the biotech sector, as companies navigate a period of unprecedented complexity.
-
Expand Bandwidth With A Trusted Regulatory Writing Partner
9/18/2025
Find out how a mid-size biotech lacking the bandwidth, expertise, and resources to independently handle its regulatory writing requirements overcame this challenge.
-
ICH E6(R3): 10 FAQ On What Changed And What It Means For Your Trials
9/18/2025
The ICH E6(R3) updated guidelines present 10 critical changes to make clinical trials more efficient, adaptable, and patient-centric, while upholding the standards of scientific and ethical integrity.
-
Inclusive Trial Design A 'Must-Have' In Modern R&D
8/14/2025
Inclusivity in trial design is a crucial aspect of the R&D process, recognized for its importance to ensuring scientific validity, ethical responsibility, and public health.
-
Gene Therapy Studies Rose While Financing Declined In Q2 2025
8/13/2025
There were three new approvals across the therapeutic landscape in the second quarter of 2025, but despite those positive signs, overall dealmaking was flat for the quarter.